Orthofix Medical Inc.
OFIX
$14.51
$0.010.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 809.03M | 804.53M | 799.49M | 784.25M | 771.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 809.03M | 804.53M | 799.49M | 784.25M | 771.65M |
| Cost of Revenue | 260.94M | 261.22M | 250.56M | 243.54M | 246.23M |
| Gross Profit | 548.09M | 543.31M | 548.93M | 540.71M | 525.42M |
| SG&A Expenses | 536.09M | 533.82M | 532.53M | 528.33M | 520.28M |
| Depreciation & Amortization | 15.80M | 16.25M | 19.78M | 19.76M | 19.57M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 884.63M | 885.20M | 876.50M | 865.40M | 861.12M |
| Operating Income | -75.60M | -80.67M | -77.01M | -81.15M | -89.47M |
| Income Before Tax | -122.70M | -140.84M | -123.88M | -116.21M | -117.96M |
| Income Tax Expenses | 1.01M | 2.23M | 2.12M | 2.81M | 2.53M |
| Earnings from Continuing Operations | -123.71 | -143.07 | -126.00 | -119.03 | -120.49 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -123.71M | -143.07M | -126.00M | -119.03M | -120.49M |
| EBIT | -75.60M | -80.67M | -77.01M | -81.15M | -89.47M |
| EBITDA | 22.16M | 14.63M | -1.05M | -15.52M | -26.34M |
| EPS Basic | -3.18 | -3.70 | -3.30 | -3.14 | -3.20 |
| Normalized Basic EPS | -1.65 | -1.89 | -1.90 | -1.72 | -1.81 |
| EPS Diluted | -3.18 | -3.70 | -3.30 | -3.14 | -3.20 |
| Normalized Diluted EPS | -1.65 | -1.89 | -1.90 | -1.72 | -1.81 |
| Average Basic Shares Outstanding | 155.88M | 154.40M | 152.95M | 151.55M | 150.31M |
| Average Diluted Shares Outstanding | 155.88M | 154.40M | 152.95M | 151.55M | 150.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |